157 related articles for article (PubMed ID: 26776196)
1. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.
Geifman N; Butte AJ
Pac Symp Biocomput; 2016; 21():309-20. PubMed ID: 26776196
[TBL] [Abstract][Full Text] [Related]
2. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
3. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT.
Gligorijević V; Malod-Dognin N; Pržulj N
Pac Symp Biocomput; 2016; 21():321-32. PubMed ID: 26776197
[TBL] [Abstract][Full Text] [Related]
4. A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials.
Geifman N; Butte AJ
Sci Data; 2016 May; 3():160027. PubMed ID: 27163794
[TBL] [Abstract][Full Text] [Related]
5. BAYESIAN BICLUSTERING FOR PATIENT STRATIFICATION.
Khakabimamaghani S; Ester M
Pac Symp Biocomput; 2016; 21():345-56. PubMed ID: 26776199
[TBL] [Abstract][Full Text] [Related]
6. COMPUTING THERAPY FOR PRECISION MEDICINE: COLLABORATIVE FILTERING INTEGRATES AND PREDICTS MULTI-ENTITY INTERACTIONS.
Regenbogen S; Wilkins AD; Lichtarge O
Pac Symp Biocomput; 2016; 21():21-32. PubMed ID: 26776170
[TBL] [Abstract][Full Text] [Related]
7. Themis: advancing precision oncology through comprehensive molecular subtyping and optimization.
Xi Y; Zheng K; Deng F; Liu Y; Sun H; Zheng Y; Tong HHY; Ji Y; Zhang Y; Chen W; Zhang Y; Zou X; Hao J
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38833322
[TBL] [Abstract][Full Text] [Related]
8. RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.
Thanintorn N; Wang J; Ersoy I; Al-Taie Z; Jiang Y; Wang D; Verma M; Joshi T; Hammer R; Xu D; Shin D
Pac Symp Biocomput; 2016; 21():417-28. PubMed ID: 26776205
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer clinical trials and accrual in the United States.
Hoos WA; James PM; Rahib L; Talley AW; Fleshman JM; Matrisian LM
J Clin Oncol; 2013 Sep; 31(27):3432-8. PubMed ID: 23960185
[TBL] [Abstract][Full Text] [Related]
10. G-DOC Plus - an integrative bioinformatics platform for precision medicine.
Bhuvaneshwar K; Belouali A; Singh V; Johnson RM; Song L; Alaoui A; Harris MA; Clarke R; Weiner LM; Gusev Y; Madhavan S
BMC Bioinformatics; 2016 Apr; 17(1):193. PubMed ID: 27130330
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: key players in carcinogenesis and novel therapeutic targets.
Mirnezami AH; Pickard K; Zhang L; Primrose JN; Packham G
Eur J Surg Oncol; 2009 Apr; 35(4):339-47. PubMed ID: 18644693
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
13. Banding Together: A Systematic Comparison of The Cancer Genome Atlas and the Mitelman Databases.
Denomy C; Germain S; Haave B; Vizeacoumar FS; Freywald A; Weaver BA; Vizeacoumar FJ
Cancer Res; 2019 Oct; 79(20):5181-5190. PubMed ID: 31416843
[TBL] [Abstract][Full Text] [Related]
14. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
15. Toward computational cumulative biology by combining models of biological datasets.
Faisal A; Peltonen J; Georgii E; Rung J; Kaski S
PLoS One; 2014; 9(11):e113053. PubMed ID: 25427176
[TBL] [Abstract][Full Text] [Related]
16. A Practical Guide to The Cancer Genome Atlas (TCGA).
Wang Z; Jensen MA; Zenklusen JC
Methods Mol Biol; 2016; 1418():111-41. PubMed ID: 27008012
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials in a rural population: professional education aspects.
Maurer LH; Davis T; Hammond S; Smith E; West P; Doolittle M
J Cancer Educ; 2001; 16(2):89-92. PubMed ID: 11440069
[TBL] [Abstract][Full Text] [Related]
18. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
19. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
20. Impact of managed care on cancer trial enrollment.
Gross CP; Krumholz HM
J Clin Oncol; 2005 Jun; 23(16):3811-8. PubMed ID: 15923575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
